
STERIS plc STE
$ 221.8
-0.77%
Quarterly report 2025-Q4
added 02-06-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
98.6 M |
Market Cap[1] |
$ 21.9 B |
EBITDA (LTM) |
$ 1.19 B |
P/E (LTM) |
29.92 |
P/S (LTM) |
3.85 |
EPS (LTM) |
7.47 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 122.35 | 0.73 % | $ 3.92 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 75.8 | -0.08 % | $ 40.4 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 3.96 | -0.75 % | $ 183 M | Nasdaq Capital Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.99 | 1.48 % | $ 26.7 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 64.42 | -0.82 % | $ 12.8 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 59.93 | 0.52 % | $ 3.02 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 6.18 | -0.08 % | $ 52.4 K | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 124.82 | 0.22 % | $ 3.08 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.8 | -0.89 % | $ 4.5 B | NYSE | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Intuitive Surgical
ISRG
|
$ 482.22 | 0.71 % | $ 172 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 23.02 | -5.07 % | $ 1.55 B | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 121.48 | 0.5 % | $ 5.88 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.2 | 0.92 % | $ 101 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 25.67 | 3.34 % | $ 1.27 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.63 | -0.04 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.32 | -1.27 % | $ 26.3 M | NYSE American | ||
|
InfuSystem Holdings
INFU
|
$ 10.34 | 0.68 % | $ 214 M | NYSE American | ||
|
Stereotaxis
STXS
|
$ 1.93 | -1.53 % | $ 176 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 68.58 | -0.04 % | $ 4.06 B | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 136.56 | -0.07 % | $ 6.09 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.17 | -1.03 % | $ 218 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 306.16 | -1.14 % | $ 22.1 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.91 | 0.08 % | $ 2.37 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.65 | 0.2 % | $ 19.5 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 52.1 | 2.24 % | $ 171 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 113.45 | 0.49 % | $ 2.57 B | Nasdaq Global Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 21.38 | -1.57 % | $ 985 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 18.16 | -1.39 % | $ 9.32 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 219.85 | 0.15 % | $ 32.1 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.28 | 3.79 % | $ 1.4 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.86 | 1.18 % | $ 305 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.1 | -0.89 % | $ 453 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 152.14 | -1.74 % | $ 43.8 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.87 | 1.06 % | $ 29.8 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.0 | -1.64 % | $ 220 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 117.6 | 3.1 % | $ 6.55 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.